Ministry of Digital Transformation: Launching the first project in Eastern Europe for treating military personnel with severe injuries

Ministry of Digital Transformation, together with the Ministry of Health of Ukraine, the Feofania Clinical Hospital, and the British company GutSee Health Limited, has signed a Memorandum of Cooperation in digital medical innovations to launch a joint AI-based project aimed at addressing antibiotic resistance in Ukraine.

The cooperation involves developing phage therapy – a modern method for treating antibiotic-resistant bacterial infections – using artificial intelligence to select personalised treatment.

“This is the first project of this scale in Eastern Europe, combining medicine, biotechnology, and artificial intelligence. Its implementation will help find new effective solutions for treating Ukrainian military personnel when conventional treatments no longer work. It is an example of how technology becomes a tool for caring for people and saving lives,” stated the First Deputy Prime Minister and Minister of Digital Transformation of Ukraine Mykhailo Fedorov.

The signing took place during the WINWIN Summit 2025: The Power of Innovations – a conference uniting representatives of government, business, education, science, and international organisations to advance innovation, artificial intelligence, and Ukraine’s digital economy.

“We are consistently working to introduce innovative approaches into Ukraine’s healthcare system. Such partnerships expand access to cutting-edge solutions that improve treatment effectiveness and better address patients’ needs,” said Mariia Karchevych, Deputy Minister of Health for Digitalisation.

Under the agreement:

• Ministry of Digital Transformation will coordinate the project as part of implementing the WINWIN Strategy for Digital Development and Innovation of Ukraine until 2030.
• The Ministry of Health will provide state-level support and help develop digital solutions in healthcare and combating antibiotic resistance.
• The Feofania Clinical Hospital will serve as the pilot clinical centre, conducting research, testing, and evaluating the effectiveness of new treatment methods.
• GutSee Health Limited will provide technologies and AI expertise, train Ukrainian doctors in new approaches, and facilitate international knowledge exchange.

Joanna Wiecek, CEO of GutSee Health, expressed enthusiasm about initiating collaboration with the Government of Ukraine and the Feofania Clinical Hospital, describing it as a significant milestone in advancing personalised phage therapy for chronic bacterial infections and highlighting its potential to rapidly save lives through innovation.

The initiative will contribute to the development of next-generation digital medicine, combining science, technology, and data to preserve lives.

“Thanks to the WINWIN Strategy, Ukraine is becoming a platform for innovative MedTech solutions that set new treatment standards and have global impact. Innovation in medicine is not just about technology – it is about the people for whom it is created. We thank our partners for their trust, openness, and shared vision for developing innovations that improve lives,” noted Valeriya Ionan, Advisor to the First Deputy Prime Minister and Minister of Digital Transformation of Ukraine on Innovation, Digitalisation and Global Partnerships.

“For us, cooperation under the signed Memorandum is primarily an opportunity to find effective solutions for treating critically ill patients where standard methods no longer work. It is an investment in knowledge and new opportunities for implementing phage therapy and personalised treatment using artificial intelligence,” remarked Ihor Semeniv, Chief Physician of the Feofania Clinical Hospital.

The cooperation is part of implementing the WINWIN Strategy for Digital Development and Innovation of Ukraine until 2030, which aims to strengthen the state’s technological potential, integrate innovations into key sectors – from healthcare to defence – and position Ukraine as a global centre for technological solutions.